TRANSMEDICS GROUP INC (TMDX) Stock News
NASDAQ:TMDX - Nasdaq - US89377M1099 - Common Stock - Currency: USD
TMDX Latest News, Press Relases and Analysis
TRANSMEDICS GROUP INC (NASDAQ:TMDX) – A High-Growth Momentum Stock with Strong Technical Setup
TRANSMEDICS (TMDX) shows strong earnings momentum with 500% EPS growth and a solid technical setup, making it a candidate for high-growth investors.
Is TransMedics Stock a Buy After Short-Seller Drama?
2 Stocks That Have Doubled This Year and Are Still Worth Buying
Mentions: FUBO
Oppenheimer Raises TransMedics (TMDX) PT to $150 Following Key OrganOx Metra Label Update
TransMedics Group Inc. (NASDAQ:TMDX) is one of the best mid cap growth stocks to invest in now. On June 17, Oppenheimer increased the price target for TransMedics to $150 from $130, while maintaining an Outperform rating on the shares. This adjustment came after the OrganOx Metra device had its air transport warning removed from its […]
TransMedics (TMDX) Continues to Scale Innovation in Organ Transplant Care
TransMedics Group Inc. (NASDAQ:TMDX) is one of the 10 best growth stocks to buy according to billionaires. The stock has had a tremendous year so far, with share price gains of 129%, leading other stocks in this list by a considerable margin, as none of the other stocks here have even reached 100%. In 2024, the […]
Mentions: GS
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May
TransMedics Group and two other mid-cap names just posted dominant performances in Q1, smashing forecasts set by Wall Street analysts.
TransMedics Group, Inc. (TMDX): A Bull Case Theory
We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc. (TMDX)’s share was trading at $130.49 as of 3rd June. TMDX’s trailing and forward P/E were 90.66and 69.93 respectively according to Yahoo Finance. TransMedics (TMDX) […]
3 Medical Technology Stocks Outperforming in 2025
Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.
TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law Firm
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of TransMedics Group, Inc. (NASDAQ:...
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
Why Archer Aviation Stock Plummeted This Week
Culper Research, a short-seller, released a report claiming Archer is misleading investors. The report contains multiple damning allegations. It's important to remember that Culper has a financial stake in seeing Archer's stock fall, so try to gather as much information as possible.
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
TransMedics to Present at Upcoming June Investor Conferences
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy?
TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes TransMedics (TMDX) a New Buy Stock
TransMedics (TMDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
Exact Sciences has helped increase colorectal cancer detection. TransMedics Group developed a revolutionary way to store organs before transplants. The company's Organ Care System (OCS) mimics the physiology of the human body, resulting in a higher usage rate for the organs it is approved for -- lungs, hearts, and kidneys -- than the traditional cold storage method.
Will Palantir Stock Join The $1 Trillion Market Cap Club by 2030? The Answer May Surprise You.
Investors are bullish on this AI defense contractor. The numbers tell a different story.
Is TransMedics Group, Inc. (TMDX) the Unstoppable Growth Stock to Invest in Now?
We recently published a list of 11 Unstoppable Growth Stocks to Invest in Now. In this article, we are going to take a look at where TransMedics Group, Inc. (NASDAQ:TMDX) stands against other unstoppable growth stocks to invest in now. BlackRock highlighted that the trade conflict between the US and China continues to cause major economic […]
This Top High-Yield Dividend Stock Has a Brilliant Strategy to Capitalize on This Growing Value Disconnect
Brookfield Renewable is always looking for opportunities to grow value for its shareholders. It's seeing a widening disconnect between public and private market values for renewable energy assets. Brookfield is capitalizing on this opportunity through its smart capital recycling strategy.
Roger Federer-backed On raises annual sales forecast as promotions, new launches fuel demand
(Reuters) -Roger Federer-backed On Holding raised its annual sales forecast on Tuesday and said it would have to undertake selective pricing to mitigate impacts from U.S. President Donald Trump's tariffs. The Trump administration has implemented a baseline 10% tariff on all trading partners globally with further tariffs on countries such as Vietnam and Indonesia on a 90-day pause. Vietnam faces a 46% tariff on exports to the U.S. if a reduction cannot be negotiated before the moratorium expires in July.
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
After a depressing 2024, TransMedics Group stock is surging in 2025. Shares of TransMedics Group (NASDAQ: TMDX) recently bounded higher in response to a first-quarter earnings report that was a lot better than investors were expecting. From the end of 2024 through the opening bell on Monday, May 12, TransMedics stock soared about 81%, and investors want to know if it can keep climbing.
Why TransMedics Group (TMDX) Is Among the Best Performing Healthcare Stocks to Buy Now
We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where TransMedics Group, Inc. (NASDAQ:TMDX) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]
Was Jim Cramer Right About Monster Beverage (MNST)?
We recently published a list of Jim Cramer’s 9 Failed Predictions From 12 Months Ago. In this article, we are going to take a look at where Monster Beverage Corporation (NASDAQ:MNST) stands against other stocks that Jim Cramer discussed 12 months ago. During a recent episode of Mad Money, which aired on Friday, the 9th of […]
TransMedics Group, Inc. (TMDX): A Bull Case Theory
We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc. (TMDX)’s share was trading at $95.81 as of May 7th. TMDX’s trailing and forward P/E were 89.54 and 63.29 respectively according to Yahoo Finance. TransMedics […]
Mentions: VZ
TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.